Date of event
Thursday, July 9, 2020 - 5:00 pm -
Thursday, July 9, 2020 - 6:00 pm
Continuing Education Credits

Content Contributors

AASLD COVID-19 Clinical Oversight Subcommittee


  • Joel Ernst, MD
    University of California San Francisco
  • Gopi Patel, MD
    Mount Sinai Hospital


  • Mark W. Russo, MD, MPH, FAASLD
    Carolinas Medical Center


  • Peter Chin-Hong, MD
    University of California, San Francisco
  • Philippe J. Zamor, MD, FAASLD
    Carolinas Medical Center
  • Mercedes Martinez, MD
    New York-Presbyterian


During this webinar speakers will discuss the different testing modalities for SARS-COV-2, the virus that causes COVID-19. The role of antibody testing, and the interpretation will be discussed as will progress towards developing an effective vaccine. As COVID-19 continues to infect more people, vaccine development continues to be a necessity and a high priority.

This webinar will:

  • Discuss differences in diagnostic testing for SARS-COV-2 including nasopharyngeal and nasal PCR testing
  • Explain the significance of positive antibody tests and the limitations associated with antibody testing
  • Review the latest developments in vaccines for SARS-COV-2

Attendees can submit their COVID-19 questions in advance via this survey. Our experts will select a few questions to discuss during the webinar. Questions must be received by Tuesday, July 7, 11:59 am ET. Once the deadline passes, you can submit your questions directly to the speakers during the live webinar, time permitting.

Presenter Bios

Joel Ernst, MD

Joel Ernst trained in Internal Medicine, Infectious Diseases, and in Hematology and Oncology at the University of California, San Francisco. He joined the faculty at UCSF where he established a research program in host-pathogen interactions and immunity, and cared for patients with infectious diseases, including the earliest AIDS patients, at San Francisco General Hospital. He was recruited to the NYU School of Medicine in 2003, where he was Director of the Division of Infectious Diseases and Immunology as well as Director of the Graduate Program in Immunology and Inflammation, and Professor of Medicine, Pathology, and Microbiology. In 2018, he was recruited to UCSF where he is Professor of Medicine and Chief of the Division of Experimental Medicine.

Dr. Ernst's research focuses on immunity to tuberculosis, to inform the rational design and development of new TB vaccines.

Graduates of the Ernst Laboratory include an HHMI Investigator and recipient of the Lasker Award in Clinical Medical Research, as well as tenured or tenure-track faculty at Stanford, Duke, the University of Michigan, and Emory, and at institutions in England, Switzerland, Canada, Sweden, and China.

Dr. Ernst’s honors include election to the American Association of Physicians and the American Academy of Microbiologists, and an Honorary Doctorate from the University of Linköping, Sweden.

Photo of Dr. Joel Ernst


Gopi Patel, MD

Gopi Patel, MD, MS is currently the Hospital Epidemiologist at The Mount Sinai Hospital in New York City and the Antimicrobial Stewardship Director for the Mount Sinai Health System. She joined the clinical faculty as a Transplant Infectious Diseases clinician at Mount Sinai after completing both her Internal Medicine and Infectious Diseases training at Mount Sinai. She is currently at Associate Professor in the Division of Infectious Diseases. Her research interests involve infection prevention, antimicrobial utilization, and infections with multidrug-resistant pathogens include carbapenem-resistant Enterobacterales and Candida auris and she has been involved in multiple studies evaluating the epidemiology and treatment of CRE. As Hospital Epidemiologist she serves as the Infection Prevention and Control lead at The Mount Sinai Hospital during the COVID-19 pandemic including advising on laboratory testing, infection prevention protocols and healthcare worker management.

Photo of Dr. Gopi Patel

Moderator Bio

Mark W. Russo, MD, MPH, FAASLD

Mark W. Russo, MD, MPH, FAASLD is Medical Director of Liver Transplantation, Chief, Division of Hepatology, and Clinical Professor of Medicine at Carolinas Medical Center-Atrium Health. In the AASLD, Dr. Russo is Chair of the Maintenance of Certification Committee, member of the Nominating Committee, co-director of the 2020 AASLD Transplant Hepatology Board Review course, and member of a working group planning for the future hepatology workforce. He is an Associate Editor for the American Journal of Gastroenterology and serves on the editorial board of Expert Reviews in Gastroenterology and Hepatology and the Journal of Clinical Medicine. He has more than 100 peer-reviewed publications and he is the editor of the textbook Diagnosis and Management of Autoimmune Hepatitis.

Photo of Dr. Mark Russo